A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

A Trial for Patients With Gestational Trophoblastic Disease

NCT00190918 ·Status: COMPLETED ·Phase: PHASE2

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

NCT00051506 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

NCT00061477 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00071136 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Comparing 3 Schedules of Alimta Plus Gemzar

NCT00034606 ·Status: COMPLETED ·Phase: PHASE2

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

NCT00630149 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

NCT00061464 ·Status: COMPLETED ·Phase: PHASE2

Alimta and Gemcitabine in Non-Small Cell Lung Cancer

NCT00434135 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial

NCT00061451 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

NCT00517595 ·Status: COMPLETED ·Phase: PHASE2

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

NCT00489983 ·Status: COMPLETED ·Phase: PHASE2

A Trial for Patients With Advanced/Recurrent Cervical Cancer

NCT00190983 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

NCT00190801 ·Status: COMPLETED ·Phase: PHASE2

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

NCT00192088 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

NCT00087711 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer

NCT00078260 ·Status: COMPLETED ·Phase: PHASE3

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

NCT00343720 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer

NCT03744793 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma

NCT00895648 ·Status: TERMINATED ·Phase: PHASE2

Pemetrexed Plus Gemcitabine in Renal Cell Cancer

NCT00491075 ·Status: TERMINATED ·Phase: PHASE2

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

NCT00191503 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer

NCT00415168 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer

NCT00383331 ·Status: TERMINATED ·Phase: PHASE2

Study of TRC102 in Combination With Pemetrexed in Cancer Patients

NCT00692159 ·Status: COMPLETED ·Phase: PHASE1

Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer

NCT00365183 ·Status: TERMINATED ·Phase: PHASE2